Meetings to be held in the Midwest April 8-9 hosted by BTIG.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AAPG:
- Ascentage Pharma Sets March 25 Board Meeting on 2025 Results and Potential Final Dividend
- Ascentage Pharma initiated with a Buy at BTIG
- Ascentage Pharma: Undervalued Long-Term Oncology Leader Backed by Late-Stage Assets Olverembatinib and Lisaftoclax
- Ascentage Pharma Sets March 25, 2026 Date to Unveil 2025 Unaudited Results and Business Update
- Ascentage Pharma Ramps Up Investor Outreach With Three U.S. Conferences